| __timestamp | Supernus Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 5496000 |
| Thursday, January 1, 2015 | 89204000 | 9786000 |
| Friday, January 1, 2016 | 106010000 | 6792000 |
| Sunday, January 1, 2017 | 137905000 | 7313000 |
| Monday, January 1, 2018 | 159888000 | 8382000 |
| Tuesday, January 1, 2019 | 158425000 | 10803000 |
| Wednesday, January 1, 2020 | 200677000 | 12944000 |
| Friday, January 1, 2021 | 304759000 | 21967000 |
| Saturday, January 1, 2022 | 377221000 | 32810000 |
| Sunday, January 1, 2023 | 336361000 | 46542000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. Over the past decade, from 2014 to 2023, Supernus Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Supernus Pharmaceuticals has consistently outpaced Xenon, with its SG&A costs growing by approximately 364% from 2014 to 2023. In contrast, Xenon Pharmaceuticals, while starting with a modest base, saw a remarkable increase of around 747% in the same period. This disparity highlights Supernus's aggressive expansion and market penetration strategies, while Xenon focuses on scaling its operations. The data reveals a fascinating narrative of growth and strategic financial management, offering insights into how these companies navigate the competitive landscape of the pharmaceutical sector.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Viatris Inc. and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Veracyte, Inc. or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.